Registry of Aortic Valve Bioprostheses Established by Catheter

Launched by FRENCH CARDIOLOGY SOCIETY · Jan 28, 2013

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment for people with a serious heart condition called severe degenerative aortic stenosis, where the heart's aortic valve becomes narrowed, making it hard for blood to flow. The trial focuses on the use of a special type of heart valve, called a bioprosthesis, which is implanted through a catheter (a thin tube) rather than traditional surgery. Researchers want to gather information about how well these valves work and how long patients survive after they receive them.

To be eligible for this trial, participants must have symptoms related to their heart condition and meet specific measurements indicating the severity of their aortic stenosis. There are no age or gender restrictions, and if you or a loved one is considering participating, you’ll need to agree to follow-up visits to monitor your health after the procedure. The trial is currently recruiting participants, so if you think you might be a candidate, it could be a great opportunity to receive care and help advance medical knowledge at the same time.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: Patients who have undergone transarterial or transapical aortic valve bioprosthesis implantation
• • Exclusion Criteria: Patient has not given consent